This Drug Could End America’s Painkiller Epidemic
If successful in human testing, PZM21 may curtail the scourge of narcotic addiction and overdose.
This article is for subscribers only.
So far, the fight against America’s opioid crisis has focused on treating addiction and curbing abuse. In February, President Barack Obama asked Congress for $1.1 billion to fund health care for addicts, and last month Congress allocated $181 million in grants for state programs.
But help could be on the way from scientists—help that could radically alter the American landscape of painkiller addiction and untimely death.